Anthem Inc now has $57.38B valuation. American Century Companies Inc. now owns 1,304,168 shares of the pharmacy operator's stock valued at $102,129,000 after buying an additional 1,199,442 shares in the last quarter. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since December 6, 2016 and is downtrending. It has outperformed by 15.16% the S&P500.
Currently, the 14-day ADX for Walgreens Boots Alliance (WBA) is sitting at 25.33.
Analysts await Walgreens Boots Alliance, Inc. The firm has a market cap of $70,879.76, a price-to-earnings ratio of 14.03, a P/E/G ratio of 1.27 and a beta of 1.22. Schwab Charles Investment Management Inc. raised its stake in Walgreens Boots Alliance by 5.4% during the second quarter. (WBA) knifed -1.94 percent lower and now trades for $70.18. The firm owned 145,853 shares of the pharmacy operator's stock after selling 4,238 shares during the quarter. There are brokerage firms with lower targets than the average, including one setting a price target of $72. (NASDAQ:WBA) has risen 5.77% since December 5, 2016 and is uptrending. It has underperformed by 10.93% the S&P500.The move comes after 6 months positive chart setup for the $69.62 billion company. Companies having a market cap of $10 billion or more are typically considered as the major players of the market. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The quick ratio, on the other hand, is 0.6 indicating the company's current short-term liquidity. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Shares of Walgreens Boots Alliance Inc (WBA) traded up $0.87 on Wednesday, reaching $71.05. Therefore 62% are positive. BidaskClub raised shares of Walgreens Boots Alliance from a "sell" rating to a "hold" rating in a research note on Wednesday, August 30th. Finally, American Century Companies Inc. lifted its stake in Walgreens Boots Alliance by 1,145.3% in the 2nd quarter.
HRB's revenue has grown at an average annualized rate of about 1% during the past five years. The company's revenue for the quarter was up 5.3% on a year-over-year basis. equities research analysts predict that Walgreens Boots Alliance Inc will post 5.55 earnings per share for the current fiscal year. WBA's financial leverage ratio is 1.36, which indicates that the company's asset base is primarily funded by equity capital. The Price Range of Walgreens Boots Alliance, Inc. Finally, Atlantic Securities raised shares of Walgreens Boots Alliance from a "neutral" rating to an "overweight" rating and set a $95.00 price objective for the company in a report on Monday, February 6th. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator's stock valued at $156,000 after purchasing an additional 87 shares during the last quarter. After $2.65 actual EPS reported by Anthem, Inc. for the previous quarter, Wall Street now forecasts -52.83% negative EPS growth. Gem Diamonds Ltd had 123 analyst reports since July 27, 2015 according to SRatingsIntel. Following the transaction, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. As per Friday, April 8, the company rating was initiated by Cleveland. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator's stock valued at $1,448,939,000 after acquiring an additional 3,662,302 shares during the period. (NYSE:ANTM) has "Outperform" rating given on Thursday, June 16 by Bernstein. Needham & Company LLC reaffirmed a "buy" rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. They set a "buy" rating and a $95.00 target price on the stock. (NASDAQ:WBA) that has shown a discernible change in trend levels over the path of recent market activity. Panmure Gordon maintained it with "Buy" rating and GBX 132 target in Monday, September 11 report. The firm earned "Buy" rating on Wednesday, November 11 by Liberum Capital.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.